March 28, 2000 - FDA opens probe into Warner-Lambert's Rezulin adverse events, reports FDA Webview
The Food and Drug Administration (FDA) has open an investigation into allegations that toxicity data for the drug Rezulin and Avandia were manipulated to keep liver toxicity reports lower than they actually were. In response, the manfacture of Rezuline, Warner-Lambert has raised claims against the FDA over regulatory marketing practices, the fast-track review process, and other complaints about alleged FDA violations within the Code of Ethics for Government Service.
If you or a loved one has suffered an injury as a result of taking any drug or supplement, call Littman & Babiarz, Attorneys at Law now at 607-277-7527 or CLICK HERE TO SUBMIT A SIMPLE CASE FORM. The initial consultation is free of charge, and if we agree to review your case, we will work on a contingent fee basis, which means we get paid for our services only if there is a monetary award or recovery of funds. Don't delay! You may have a valid claim and be entitled to compensation for your injuries, but a lawsuit must be filed before the statute of limitations expires.
<< back
The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.
